This subcutaneous peptide injection guide outlines the decision criteria that should inform route selection in research contexts
How to Choose the Right Peptide for Your Goals No two patients are the same, and no single peptide addresses every need
We answer these questions before anything gets prescribed: We build a strategy around the individual, the goal, the full clinical picture, and whether the approach is effective
Treatment durations in clinical practice range from 4 to 12 weeks for conditions like gastric erosions, NSAID-related gastropathy, or presumed intestinal permeability ("leaky gut")
RESULTS Here, to evidence a link between inflammatory bowel disease and multiple sclerosis that may be useful in practice, BPC 157 was used per-orally in rats subjected to cysteamine enema + colon-colon anastomosis colitis (9-11) and over-dose cuprizone application, a multiple sclerosis suited toxic experimental model (12)